Clay B. Siegall

2021

In 2021, Clay B. Siegall earned a total compensation of $18.9M as President and CEO at Seattle Genetics, a 15% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$1,835,467
Option Awards$4,831,830
Salary$1,133,969
Stock Awards$10,985,182
Other$119,996
Total$18,906,444

Siegall received $11M in stock awards, accounting for 58% of the total pay in 2021.

Siegall also received $1.8M in non-equity incentive plan, $4.8M in option awards, $1.1M in salary and $120K in other compensation.

Rankings

In 2021, Clay B. Siegall's compensation ranked 362nd out of 12,415 executives tracked by ExecPay. In other words, Siegall earned more than 97.1% of executives.

ClassificationRankingPercentile
All
362
out of 12,415
97th
Division
Manufacturing
109
out of 5,505
98th
Major group
Chemicals And Allied Products
34
out of 2,375
99th
Industry group
Drugs
30
out of 2,096
99th
Industry
Biological Products, Except Diagnostic Substances
14
out of 449
97th

Pay ratio

Clay B. Siegall's Pay$18,906,444
Median Employee's Pay$250,158
Pay Ratio

76

to 1

In 2021, the annual total compensation of Clay B. Siegall was $18,906,444.

The annual total compensation of the median employee at Seattle Genetics was $250,158.

The ratio of Clay B. Siegall's pay to the pay of median employee was therefore 76 to one.

Source: SEC filing on March 30, 2022.

Siegall's colleagues

We found four more compensation records of executives who worked with Clay B. Siegall at Seattle Genetics in 2021.

2021

Roger Dansey

Seattle Genetics

Chief Medical Officer

2021

Todd Simpson

Seattle Genetics

Chief Financial Officer

2021

Chip Romp

Seattle Genetics

Executive Vice President, Commercial U.S

2021

Jean Liu

Seattle Genetics

Chief Legal Officer

News

You may also like